Your Search Returned 500 tagged news reports
The Morehouse School of Medicine is creating what is being called the first endowed chair on sexuality and religion at a U.S. medical school. The Atlanta medical school on Thursday announced it raised $2 million for the endowed
The Food and Drug Administration is warning a Johnson & Johnson unit that it failed to look into dozens of consumer complaints about its K-Y Liquibeads Vaginal Moisturizer and other products in the last two years. The FDA sent a
Reuters U.S. drug regulators chided a Johnson & Johnson unit for not reporting or investigating customer complaints about O.B...The Food and Drug Administration said the unit, McNeil-PPC Inc, did not properly follow up on complaints that included
Just one month into his new job as ceo at Johnson & Johnson and Alex Gorsky has received his first warning letter from the FDA. Actually, the May 22 letter was addressed to Teresa Gorecki, who is vp of quality assurance at McNeil PPC, a J&J unit that
as safe havens, especially in the midst of a steady, growing American economy. All 30 components offer dividends to investors and global exposure to further mitigate their downside risk. However, not all companies experience smooth sailing in calm
Satcher speaks Saturday Former Surgeon General David Satcher will give the commencement address Saturday for graduates of Des Moines University, which trains osteopathic physicians and other health professionals. The event, which is open to the
Just one month after becoming Johnson & Johnson ceo, Alex Gorsky is presiding over a product recall, the latest in an endless stream of such actions taken by the health care giant over the past two years. This time, the McNeil Consumer Healthcare
Pennsylvania still trying get a slice of J&J Risperdal payouts An appeal being heard today on a case seen as the precursor to the mountains of litigation over Johnson & Johnson's ($JNJ) Risperdal may decide whether Pennsylvania will see any of the
www.hebrew.schizophrenia24x7.com, provides information on the illness and treatment options, and directs visitors to potential sources of help.
Johnson & Johnson's incoming CEO plans to present himself as a "realistic optimist" when he addresses shareholders at the health care giant's annual meeting Thursday. Alex Gorsky, a J&J vice chairman who succeeds Bill Weldon later this month, says he'